当前位置: X-MOL 学术Chem. Bio. Drug Des. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Pharmacological and SAR analysis of the LINS01 compounds at the human histamine H1, H2, and H3 receptors
Chemical Biology & Drug Design ( IF 3 ) Pub Date : 2018-09-24 , DOI: 10.1111/cbdd.13387
Michelle Fidelis Corrêa 1 , Álefe Jhonatas Ramos Barbosa 1 , Gustavo Ariel Borges Fernandes 1 , Jillian G. Baker 2 , João Paulo dos Santos Fernandes 1
Affiliation  

Histamine is a transmitter that activates the four receptors H1R to H4R. The H3R is found in the nervous system as an autoreceptor and heteroreceptor, and controls the release of neurotransmitters, making it a potential drug target for neuropsychiatric conditions. We have previously reported that the 1‐(2,3‐dihydro‐1‐benzofuran‐2‐yl)methylpiperazines (LINS01 compounds) have the selectivity for the H3R over the H4R. Here, we describe their pharmacological properties at the human H1R and H2R in parallel with the H3R, thus providing a full analysis of these compounds as histamine receptor ligands through reporter gene assays. Eight of the nine LINS01 compounds inhibited H3R‐induced histamine responses, but no inhibition of H2R‐induced responses was seen. Three compounds were weakly able to inhibit H1R‐induced responses. No agonist responses were seen to any of the compounds at any receptor. SAR analysis shows that the N‐methyl group improves H3R affinity while the N‐phenyl group is detrimental. The methoxy derivative, LINS01009, had the highest affinity.

中文翻译:

LINS01化合物在人组胺H1,H2和H3受体上的药理和SAR分析

组胺是激活的四种受体h的发射机1 R键ħ 4 R.为H 3中的R神经系统作为自身受体和heteroreceptor,和控制神经递质的释放被发现,使之成为神经精神病症的潜在药物靶。我们先前已报道了1-(2,3-二氢-1-苯并呋喃-2-基)methylpiperazines(LINS01化合物)具有对H的选择性3 R经由为H 4 R.在这里,我们描述了其药理学性质,在人类H 1 R和H 2 R与H 3平行R,因此可通过报告基因分析全面分析作为组胺受体配体的这些化合物。九种LINS01化合物中有八种抑制H 3 R诱导的组胺反应,但没有抑制H 2 R诱导的反应。三种化合物几乎不能抑制H 1 R诱导的反应。在任何受体上均未观察到对任何化合物的激动剂反应。SAR分析表明,N-甲基可改善H 3 R亲和力,而N-苯基则有害。甲氧基衍生物LINS01009具有最高的亲和力。
更新日期:2018-09-24
down
wechat
bug